A detailed history of Tower Research Capital LLC (Trc) transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 10,706 shares of CLDX stock, worth $265,187. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,706
Previous 13,102 18.29%
Holding current value
$265,187
Previous $484,000 25.0%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$32.06 - $44.56 $76,815 - $106,765
-2,396 Reduced 18.29%
10,706 $363,000
Q2 2024

Aug 13, 2024

BUY
$32.76 - $42.56 $405,142 - $526,339
12,367 Added 1682.59%
13,102 $484,000
Q1 2024

May 15, 2024

SELL
$35.22 - $51.88 $83,788 - $123,422
-2,379 Reduced 76.4%
735 $30,000
Q4 2023

Feb 13, 2024

BUY
$22.61 - $40.65 $28,059 - $50,446
1,241 Added 66.26%
3,114 $123,000
Q3 2023

Nov 14, 2023

SELL
$25.45 - $37.46 $63,523 - $93,500
-2,496 Reduced 57.13%
1,873 $51,000
Q2 2023

Aug 14, 2023

BUY
$30.29 - $38.28 $66,365 - $83,871
2,191 Added 100.6%
4,369 $148,000
Q1 2023

May 09, 2023

BUY
$34.78 - $47.43 $65,003 - $88,646
1,869 Added 604.85%
2,178 $78,000
Q4 2022

Feb 10, 2023

SELL
$27.78 - $45.38 $180,458 - $294,788
-6,496 Reduced 95.46%
309 $13,000
Q3 2022

Nov 10, 2022

SELL
$22.7 - $37.57 $103,988 - $172,108
-4,581 Reduced 40.23%
6,805 $192,000
Q2 2022

Aug 15, 2022

BUY
$20.5 - $37.33 $166,562 - $303,306
8,125 Added 249.16%
11,386 $307,000
Q1 2022

May 12, 2022

SELL
$27.64 - $39.32 $8,817 - $12,543
-319 Reduced 8.91%
3,261 $111,000
Q4 2021

Feb 14, 2022

SELL
$35.68 - $56.27 $304,172 - $479,701
-8,525 Reduced 70.43%
3,580 $138,000
Q3 2021

Nov 15, 2021

BUY
$28.95 - $55.99 $311,444 - $602,340
10,758 Added 798.66%
12,105 $654,000
Q2 2021

Aug 16, 2021

BUY
$20.71 - $35.37 $27,896 - $47,643
1,347 New
1,347 $45,000
Q1 2021

May 17, 2021

SELL
$16.19 - $29.91 $114,171 - $210,925
-7,052 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$14.99 - $22.75 $105,709 - $160,433
7,052 New
7,052 $124,000
Q2 2020

Aug 13, 2020

SELL
$1.61 - $13.41 $7,797 - $64,944
-4,843 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$1.55 - $3.07 $83 - $165
54 Added 1.13%
4,843 $8,000
Q4 2019

Feb 07, 2020

BUY
$2.11 - $2.8 $4,859 - $6,448
2,303 Added 92.64%
4,789 $11,000
Q3 2019

Nov 05, 2019

BUY
$2.05 - $2.75 $5,096 - $6,836
2,486 New
2,486 $5,000
Q2 2019

Aug 13, 2019

SELL
$2.43 - $5.09 $4,201 - $8,800
-1,729 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$3.45 - $10.35 $5,965 - $17,895
1,729 New
1,729 $9,000

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.16B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.